1. Home
  2. Clinical Topics
  3. Cardio-Pulmonary
  4. FDA approves new hemophilia treatment
Cardio-PulmonaryClinical TopicsDrugs and DevicesEndocrinologyNewsWeb Exclusives

FDA approves new hemophilia treatment

Share

On June 6, the U.S. Food and Drug Administration (FDA) approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A. Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts